5-[2-(3-fluoro-4-morpholin-4-ylphenyl)-1H-indol-4-yl]-2-(oxan-4-yloxy)benzonitrile;3-[2-(4-morpholin-4-ylphenyl)-1H-indol-4-yl]benzonitrile;5-[2-(3-morpholin-4-ylphenyl)-1H-indol-4-yl]-2-(oxan-4-yloxy)benzonitrile
C85H78FN9O7 — CID 158939943
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[2-(3-fluoro-4-morpholin-4-ylphenyl)-1H-indol-4-yl]-2-(oxan-4-yloxy)benzonitrile;3-[2-(4-morpholin-4-ylphenyl)-1H-indol-4-yl]benzonitrile;5-[2-(3-morpholin-4-ylphenyl)-1H-indol-4-yl]-2-(oxan-4-yloxy)benzonitrile
5-[2-(3-fluoro-4-morpholin-4-ylphenyl)-1H-indol-4-yl]-2-(oxan-4-yloxy)benzonitrile;3-[2-(4-morpholin-4-ylphenyl)-1H-indol-4-yl]benzonitrile;5-[2-(3-morpholin-4-ylphenyl)-1H-indol-4-yl]-2-(oxan-4-yloxy)benzonitrile (PubChem CID 158939943) has the molecular formula C85H78FN9O7 and a molecular weight of 1356.61 g/mol. Its IUPAC name is 5-[2-(3-fluoro-4-morpholin-4-ylphenyl)-1H-indol-4-yl]-2-(oxan-4-yloxy)benzonitrile;3-[2-(4-morpholin-4-ylphenyl)-1H-indol-4-yl]benzonitrile;5-[2-(3-morpholin-4-ylphenyl)-1H-indol-4-yl]-2-(oxan-4-yloxy)benzonitrile.
Molecular Properties
| Compound Name | 5-[2-(3-fluoro-4-morpholin-4-ylphenyl)-1H-indol-4-yl]-2-(oxan-4-yloxy)benzonitrile;3-[2-(4-morpholin-4-ylphenyl)-1H-indol-4-yl]benzonitrile;5-[2-(3-morpholin-4-ylphenyl)-1H-indol-4-yl]-2-(oxan-4-yloxy)benzonitrile |
|---|---|
| PubChem CID | 158939943 |
| Molecular Formula | C85H78FN9O7 |
| Molecular Weight | 1356.61 g/mol |
| Exact Mass | 1355.60 |
| IUPAC Name | 5-[2-(3-fluoro-4-morpholin-4-ylphenyl)-1H-indol-4-yl]-2-(oxan-4-yloxy)benzonitrile;3-[2-(4-morpholin-4-ylphenyl)-1H-indol-4-yl]benzonitrile;5-[2-(3-morpholin-4-ylphenyl)-1H-indol-4-yl]-2-(oxan-4-yloxy)benzonitrile |
| SMILES | N#Cc1cc(-c2cccc3[nH]c(-c4ccc(N5CCOCC5)c(F)c4)cc23)ccc1OC1CCOCC1.N#Cc1cc(-c2cccc3[nH]c(-c4cccc(N5CCOCC5)c4)cc23)ccc1OC1CCOCC1.N#Cc1cccc(-c2cccc3[nH]c(-c4ccc(N5CCOCC5)cc4)cc23)c1 |
| InChI | InChI=1S/C30H28FN3O3.C30H29N3O3.C25H21N3O/c31-26-17-21(4-6-29(26)34-10-14-36-15-11-34)28-18-25-24(2-1-3-27(25)33-28)20-5-7-30(22(16-20)19-32)37-23-8-12-35-13-9-23;31-20-23-17-21(7-8-30(23)36-25-9-13-34-14-10-25)26-5-2-6-28-27(26)19-29(32-28)22-3-1-4-24(18-22)33-11-15-35-16-12-33;26-17-18-3-1-4-20(15-18)22-5-2-6-24-23(22)16-25(27-24)19-7-9-21(10-8-19)28-11-13-29-14-12-28/h1-7,16-18,23,33H,8-15H2;1-8,17-19,25,32H,9-16H2;1-10,15-16,27H,11-14H2 |
| InChIKey | JKCVDVFJRQSEEJ-UHFFFAOYSA-N |
| XLogP | 16.89 |
| TPSA | 193.07 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 102 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1356.61 |
| LogP ≤ 5 | 16.89 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 13 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'anil_di_alk_G(9)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158939943 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.